Mark Pollack, MD

Articles by Mark Pollack, MD

Psychedelic Therapy Development for Peripartum Disorders

ByMark Pollack, MD

May 29th 2026

Luvesilocin enters phase 2, hinting at lasting relief after 1–2 doses and a new 5-HT2A model.

Luvesilocin for Postpartum Depression: Fast-Acting Treatment

ByMark Pollack, MD

May 29th 2026

Phase 2 data suggest luvesilocin quickly eases postpartum depression with durable remission and minimal breast‑milk transfer, supporting larger trials.

Mark Pollack, MD

Articles by Mark Pollack, MD

Psychedelic Therapy Development for Peripartum Disorders

Luvesilocin for Postpartum Depression: Fast-Acting Treatment

Latest Updated Articles

Trending on Psychiatric Times

Sex Differences, Sleep Problems, and Psychological Well-Being in Older Adults

Evidence-Based Nonpharmacological Interventions in Schizophrenia: Focus on Cognitive Impairment

The Association Between Sleep, Sex Differences, and Mental Health Across the Lifespan

How Can Sleep Disruption Trigger Mood Episodes?

Connecting REM Sleep and Substance Use Vulnerability